Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (21-30 of 332) with videos related to

Pageof 34
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2012
Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?Robert E Becker, Nigel H Greig
Current Pharmaceutical Design|January 31, 2016
Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and DevelopmentMohammad A Kamal, Nigel H Greig
Alzheimer'S & Dementia (New York, N. Y.)|December 20, 2017
Drug discovery and development: Role of basic biological researchRichard C Mohs, Nigel H Greig
Current Alzheimer Research|October 3, 2007
TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targetsDavid Tweedie, Kumar Sambamurti, Nigel H Greig
Frontiers in Psychiatry|March 22, 2021
Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for TreatmentMarcella Reale, Erica Costantini, Nigel H Greig
Neuromolecular Medicine|May 25, 2002
Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's diseaseKumar Sambamurti, Nigel H Greig, Debomoy K Lahiri
Clinical Neuropharmacology|June 11, 2004
Acetylcholinesterase and its inhibition in Alzheimer diseaseRoger M Lane, Miia Kivipelto, Nigel H Greig
Current Neuropharmacology|December 22, 2022
Modelling the Interplay Between Neuron-Glia Cell Dysfunction and Glial Therapy in Autism Spectrum DisorderAziz Unnisa, Nigel H Greig, Mohammad Amjad Kamal
Neural Regeneration Research|April 14, 2023
Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer's diseaseAziz Unnisa, Nigel H Greig, Mohammad Amjad Kamal
Bioorganic & Medicinal Chemistry Letters|July 12, 2024
2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparationsMichael T Scerba, David Tweedie, Nigel H Greig
Pageof 34

Showing results (21-30 of 332) with videos related to

Sort By:
Pageof 34
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2012
Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?Robert E Becker, Nigel H Greig
Current Pharmaceutical Design|January 31, 2016
Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and DevelopmentMohammad A Kamal, Nigel H Greig
Alzheimer'S & Dementia (New York, N. Y.)|December 20, 2017
Drug discovery and development: Role of basic biological researchRichard C Mohs, Nigel H Greig
Current Alzheimer Research|October 3, 2007
TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targetsDavid Tweedie, Kumar Sambamurti, Nigel H Greig
Frontiers in Psychiatry|March 22, 2021
Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for TreatmentMarcella Reale, Erica Costantini, Nigel H Greig
Neuromolecular Medicine|May 25, 2002
Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's diseaseKumar Sambamurti, Nigel H Greig, Debomoy K Lahiri
Clinical Neuropharmacology|June 11, 2004
Acetylcholinesterase and its inhibition in Alzheimer diseaseRoger M Lane, Miia Kivipelto, Nigel H Greig
Current Neuropharmacology|December 22, 2022
Modelling the Interplay Between Neuron-Glia Cell Dysfunction and Glial Therapy in Autism Spectrum DisorderAziz Unnisa, Nigel H Greig, Mohammad Amjad Kamal
Neural Regeneration Research|April 14, 2023
Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer's diseaseAziz Unnisa, Nigel H Greig, Mohammad Amjad Kamal
Bioorganic & Medicinal Chemistry Letters|July 12, 2024
2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparationsMichael T Scerba, David Tweedie, Nigel H Greig
Pageof 34